IEQ Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.9K Sell
85,899
-10,713
-11% -$4.06K ﹤0.01% 1935
2026
Q2
$41.2K Buy
96,612
+29,646
+44% +$23.8K ﹤0.01% 1994
2026
Q1
$53.6K Buy
66,966
+49,978
+294% +$57.9K ﹤0.01% 1839
2025
Q4
$22.1K Sell
16,988
-62,037
-79% -$76.6K ﹤0.01% 1825
2025
Q3
$100K Buy
+79,025
New +$125K ﹤0.01% 1766

Other funds holding HRTX

IEQ Capital's HRTX Position: Q3 2026 in Review

IEQ Capital reduced its Heron Therapeutics (HRTX) stake by 11% in Q3 2026, selling an estimated $4.06K and leaving 85,899 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

IEQ Capital first reported a position in HRTX in Q3 2025 and has held it in 5 quarters since. The position peaked at $100K in Q3 2025. 158 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • IEQ Capital held 85,899 shares of Heron Therapeutics worth $26.9K as of Q3 2026.
  • IEQ Capital sold 10,713 Heron Therapeutics shares in Q3 2026, an estimated $4.06K.
  • Heron Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1935 holding.
  • IEQ Capital first reported a position in Heron Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • IEQ Capital's Heron Therapeutics position peaked at $100K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.